• $5.1M
    Market Cap
  • -68.42%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 34
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

Sleep.ai to Present 10 Scientific Studies at SLEEP 2026, Highlighting Advances in Digital Sleep Intelligence and Product Validation

Sleep.ai announced that 10 scientific studies will be presented at SLEEP 2026, including three original AI/ML analyses on smartphone-based sleep detection and sleep apnea prediction, plus seven partner validation studies on sleep-related products. The presentations underscore Sleep.ai's commitment to evidence-based sleep innovation, leveraging over one billion hours of sleep data and 250+ scientific studies.

06/11/2026, 9:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$0.002
$0.003
$0.003
1-Year Range
$0.001
$0.010
$0.003
Latest Close$0.003
Change
+$0.0007 (+23.33%)
Volume3,742,689
Market Cap$5.1M
Shares Outstanding1.7B
P/E (TTM)-1.87
Diluted EPS (TTM)-$0.002
Enterprise Value$5.1M

Information as of 06/23/2026

Company Profile

RemSleep Holdings Inc.
https://remsleep.com
$5.1M
Market Cap
-$2.6M
Net Income
Sector: Healthcare
Industry: Medical Devices
3222 HWY 84, Blackshear, GA, United States, 31516
902 590 2001

REMSleep Holdings, Inc., focuses on the development and distribution of products to help people affected by sleep apnea worldwide. The company offers DeltaWave CPAP interface device to treat patients with sleep apnea. It serves durable medical equipment providers, hospital and acute care facilities, sleep labs, physicians, sleep and neurology, and medical associations. The company is headquartered in Blackshear, Georgia.

Key Executives

  • Jeffrey Marshall
  • Peter Downey
  • Teresita Rubio
  • Irina Veselinovic
  • Sanja Pekovic

Current Ownership Distribution

  • Other971.6M (57.34%)
  • Insiders713.6M (42.11%)
  • Institutions9.4M (0.55%)
  • Mutual Funds0 (0.00%)